追加説明:
This service runs onsite or offsite gap analyses of pharmaceutical quality management systems against Chinese GMP, cGMP, EudraLex GMP, PIC/S GMP, and WHO GMP requirements, provides recommendations for closing identified gaps, conducts mock audits with support in resolving findings, and offers onsite technical and interpretation assistance plus corrective-action advice during official inspections by NMPA, US FDA, EU authorities, and others.
評価とコメントを残す